Loading...
OTCM
HDRPF
Market cap5mUSD
Jul 02, Last price  
0.00USD
IPO
-99.78%
Name

Epsilon Healthcare Ltd

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.10
EPS
Div Yield, %
Shrs. gr., 5y
18.48%
Rev. gr., 5y
30.17%
Revenues
7m
+29.36%
01,902,9142,664,0944,792,2587,358,8885,498,1497,112,194
Net income
-13m
L+42.31%
0-2,558,525-8,611,270-11,679,182-10,947,661-8,908,397-12,677,469
CFO
-3m
L-52.65%
00-5,850,105-7,855,445-8,693,782-5,429,416-2,570,652

Profile

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
IPO date
May 04, 2017
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑09
Income
Revenues
7,112
29.36%
Cost of revenue
10,406
Unusual Expense (Income)
NOPBT
(3,294)
NOPBT Margin
Operating Taxes
822
Tax Rate
NOPAT
(4,116)
Net income
(12,677)
42.31%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,778
BB yield
-76.95%
Debt
Debt current
2,539
Long-term debt
1,309
Deferred revenue
Other long-term liabilities
(11)
Net debt
2,987
Cash flow
Cash from operating activities
(2,571)
CAPEX
(529)
Cash from investing activities
(529)
Cash from financing activities
1,607
FCF
(262)
Balance
Cash
862
Long term investments
Excess cash
506
Stockholders' equity
9,881
Invested Capital
11,952
ROIC
ROCE
EV
Common stock shares outstanding
300,354
Price
0.03
-64.79%
Market cap
7,509
-45.22%
EV
10,496
EBITDA
(1,439)
EV/EBITDA
Interest
578
Interest/NOPBT